2013; 72(2):539-49. Venook AP , Niedzwiecki D, Lenz HJ, et al. Effect of First -Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild -Type Advanced or Metastatic Colorectal Cancer. JAMA.